IXI vs. OCTP, FAB, VAL, BSFA, GENF, APTA, ROQ, EVG, NFX, and PYC
Should you be buying IXICO stock or one of its competitors? The main competitors of IXICO include Oxford Cannabinoid Technologies (OCTP), Fusion Antibodies (FAB), ValiRx (VAL), BSF Enterprise (BSFA), Genflow Biosciences (GENF), Aptamer Group (APTA), Roquefort Therapeutics (ROQ), Evgen Pharma (EVG), Nuformix (NFX), and Physiomics (PYC). These companies are all part of the "biotechnology" industry.
IXICO (LON:IXI) and Oxford Cannabinoid Technologies (LON:OCTP) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, earnings, community ranking, profitability, valuation, institutional ownership and risk.
IXICO has a beta of 0.67, meaning that its stock price is 33% less volatile than the S&P 500. Comparatively, Oxford Cannabinoid Technologies has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500.
IXICO has higher revenue and earnings than Oxford Cannabinoid Technologies.
56.9% of IXICO shares are held by institutional investors. Comparatively, 14.1% of Oxford Cannabinoid Technologies shares are held by institutional investors. 29.0% of IXICO shares are held by insiders. Comparatively, 29.8% of Oxford Cannabinoid Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
IXICO received 144 more outperform votes than Oxford Cannabinoid Technologies when rated by MarketBeat users.
In the previous week, IXICO had 1 more articles in the media than Oxford Cannabinoid Technologies. MarketBeat recorded 1 mentions for IXICO and 0 mentions for Oxford Cannabinoid Technologies. IXICO's average media sentiment score of 0.99 beat Oxford Cannabinoid Technologies' score of 0.00 indicating that IXICO is being referred to more favorably in the media.
Oxford Cannabinoid Technologies has a net margin of 0.00% compared to IXICO's net margin of -17.67%. IXICO's return on equity of -9.85% beat Oxford Cannabinoid Technologies' return on equity.
Summary
IXICO beats Oxford Cannabinoid Technologies on 8 of the 12 factors compared between the two stocks.
Get IXICO News Delivered to You Automatically
Sign up to receive the latest news and ratings for IXI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding IXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools